4
Changes in Ownership
Silence Therapeutics plc Filed Acc 0001415889-25-000743
Options or other derivatives
- President and CEO acquired 900,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
TOOMAN CRAIG A · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Grant or award : show line 1 in the form Employee Share Option (Right to Buy) | +900,000 | 900,000 | D |
Loading xslF345X05/form4-01062025_040101.xml…